首页 › 基金 › Polymer Capital Management (HK) LTD › BIIB

Polymer Capital Management (HK) LTD 对 BIIB 的持仓历史

BIOGEN INC · 医疗保健

Polymer Capital Management (HK) LTD 在 Q2 2026 的 13F 申报中披露持有 BIIB(BIOGEN INC)38,665 股,市值约 US$8.4M,约占其申报组合的 0.42%,在其申报持仓中市值排名第 32 位。 Polymer Capital Management (HK) LTD 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)38.66K 股
申报持仓市值$8.35M
组合权重0.42%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Polymer Capital Management (HK) LTD 对 BIIB 的持仓演变

Polymer Capital Management (HK) LTD 于 Q2 2026 首次披露 BIIB 持仓:38,665 股(约 US$8.4M)。

逐季持仓明细

季度股数金额变化
Q2 2026 38.66K $8.35M 新进

关于 BIIB 与 13F 数据

BIIB(BIOGEN INC)属于医疗保健行业。我们追踪的基金中还有 22 只申报持有 BIIB,申报仓位最大的包括:PRIMECAP MANAGEMENT CO/CA/ (US$3.27B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 BIIB 的基金

查看 BIIB 的全部基金持有人 →

常见问题

How long has Polymer Capital Management (HK) LTD held BIIB?

Polymer Capital Management (HK) LTD has disclosed BIIB holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Polymer Capital Management (HK) LTD's current position in BIIB?

As of Q2 2026, Polymer Capital Management (HK) LTD holds 38.66K shares of BIIB (BIOGEN INC), valued at $8.35M, representing 0.42% of its reported portfolio and ranking #32.

Has Polymer Capital Management (HK) LTD been buying or selling BIIB?

In the latest 13F filing (Q2 2026), Polymer Capital Management (HK) LTD newly opened its position in BIIB.

Which other funds hold BIIB?

Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.